The antiserum was produced against synthesized peptide derived from human Integrin beta1 around the phosphorylation site of Thr789. AA range:749-798

Phospho-Integrin β1 (T789) Polyclonal Antibody detects endogenous levels of Integrin β1 protein only when phosphorylated at T789.The name of modified sites may be influenced by many factors, such as species (the modified site was not originally found in human samples) and the change of protein sequence (the previous protein sequence is incomplete, and the protein sequence may be prolonged with the development of protein sequencing technology). When naming, we will use the "numbers" in historical reference to keep the sites consistent with the reports. The antibody binds to the following modification sequence (lowercase letters are modification sites):VTtVV

ITGB1

Integrin beta-1

ITGB1 ;
FNRB ;
MDF2 ;
MSK12 ;
Integrin beta-1 ;
Fibronectin receptor subunit beta ;
VLA-4 subunit beta ;
CD antigen CD29

Integrins are heterodimeric proteins made up of alpha and beta subunits. At least 18 alpha and 8 beta subunits have been described in mammals. Integrin family members are membrane receptors involved in cell adhesion and recognition in a variety of processes including embryogenesis , hemostasis , tissue repair , immune response and metastatic diffusion of tumor cells. This gene encodes a beta subunit. Multiple alternatively spliced transcript variants which encode different protein isoforms have been found for this gene. [provided by RefSeq , Jul 2008] ,

Function:Integrins alpha-1/beta-1 , alpha-2/beta-1 , alpha-10/beta-1 and alpha-11/beta-1 are receptors for collagen. Integrins alpha-1/beta-1 and alpha-2/beta-2 recognize the proline-hydroxylated sequence G-F-P-G-E-R in collagen. Integrins alpha-2/beta-1 , alpha-3/beta-1 , alpha-4/beta-1 , alpha-5/beta-1 , alpha-8/beta-1 , alpha-10/beta-1 , alpha-11/beta-1 and alpha-V/beta-1 are receptors for fibronectin. Alpha-4/beta-1 recognizes one or more domains within the alternatively spliced CS-1 and CS-5 regions of fibronectin. Integrin alpha-5/beta-1 is a receptor for fibrinogen. Integrin alpha-1/beta-1 , alpha-2/beta-1 , alpha-6/beta-1 and alpha-7/beta-1 are receptors for lamimin. Integrin alpha-4/beta-1 is a receptor for VCAM1. It recognizes the sequence Q-I-D-S in VCAM1. Integrin alpha-9/beta-1 is a receptor for VCAM1 , cytotactin and osteopontin. It recognizes the sequence A-E-I-D-G-I-E-L in cytotactin. Integrin alpha-3/beta-1 is a receptor for epiligrin , thrombospondin and CSPG4. Alpha-3/beta-1 may mediate with LGALS3 the stimulation by CSPG4 of endothelial cells migration. Integrin alpha-V/beta-1 is a receptor for vitronectin. Beta-1 integrins recognize the sequence R-G-D in a wide array of ligands. Isoform beta-1B interferes with isoform beta-1A resulting in a dominant negative effect on cell adhesion and migration (in vitro) . In case of HIV-1 infection , the interaction with extracellular viral Tat protein seems to enhance angiogenesis in Kaposi's sarcoma lesions. When associated with alpha-7/beta-1 integrin , regulates cell adhesion and laminin matrix deposition. Involved in promoting endothelial cell motility and angiogenesis. May be involved in up-regulation of the activity of kinases such as PKC via binding to KRT1. Together with KRT1 and GNB2L1/RACK1 , serves as a platform for SRC activation or inactivation. Plays a mechanistic adhesive role during telophase , required for the successful completion of cytokinesis. ,online information:CD29 entry ,PTM:The cysteine residues are involved in intrachain disulfide bonds. ,similarity:Belongs to the integrin beta chain family. ,similarity:Contains 1 VWFA domain. ,subcellular location:Isoform beta-1B does not localize to focal adhesions. Highly enriched in stage I melanosomes. Located on plasma membrane of neuroblastoma NMB7 cells. In a lung cancer cell line , in prometaphase and metaphase , localizes diffusely at the membrane and in afew intracellular vesicles. In early telophase , detected mainly on the matrix-facing side of the cells. By mid-telophase , concentrated to the ingressing cleavage furrow , mainly to the basal side of the furrow. In late telophase , concentrated to the extending protrusions formed at the opposite ends of the spreading daughter cells , in vesicles at the base of the lamellipodia formed by the separating daughter cells. ,subunit:Heterodimer of an alpha and a beta subunit. Beta-1 associates with either alpha-1 , alpha-2 , alpha-3 , alpha-4 , alpha-5 , alpha-6 , alpha-7 , alpha-8 , alpha-9 , alpha-10 , alpha-11 or alpha-V. Binds LGALS3BP and ITGB1BP3 , when associated with alpha-7 , but not with alpha-5. Interacts with FLNA , FLNB and RANBP9. Isoform Beta-1D interacts with ACE2. Isoform Beta-1A interacts with the C-terminal region of FLNC. Interacts with KRT1 in the presence of GNB2L1 and SRC. Interacts with HIV-1 Tat. Binds to human echoviruses 1 and 8 capsid proteins and acts as a receptor for these viruses. Interacts with RAB21. ,tissue specificity:Isoform beta-1A is widely expressed , other isoforms are generally coexpressed with a more restricted distribution. Isoform beta-1B is expressed in skin , liver , skeletal muscle , cardiac muscle , placenta , umbelical vein endothelial cells , neuroblastoma cells , lymphoma cells , hepatoma cells and astrocytoma cells. Isoform beta-1C and isoform beta-1C-2 are expressed in muscle , kidney , liver , placenta , cervical epithelium , umbilical vein endothelial cells , fibroblast cells , embryonal kidney cells , platelets and several blood cell lines. Isoform beta-C-2 , rather than isoform beta-1C , is selectively expressed in peripheral T-cells. Isoform beta-1C is expressed in non-proliferating and differentiated prostate gland epithelial cells and in platelets , on the surface of erythroleukemia cells and in various hematopoietic cell lines. Isoform beta-1D is expressed specifically in striated muscle (skeletal and cardiac muscle) . ,

Cell membrane ; Single-pass type I membrane protein . Cell projection , invadopodium membrane ; Single-pass type I membrane protein . Cell projection , ruffle membrane ; Single-pass type I membrane protein . Recycling endosome . Melanosome . Cleavage furrow . Cell projection , lamellipodium . Cell projection , ruffle . Cell junction , focal adhesion . Cell surface . Isoform 2 does not localize to focal adhesions. Highly enriched in stage I melanosomes. Located on plasma membrane of neuroblastoma NMB7 cells. In a lung cancer cell line , in prometaphase and metaphase , localizes diffusely at the membrane and in a few intracellular vesicles. In early telophase , detected mainly on the matrix-facing side of the cells. By mid-telophase , concentrated to the ingressing cleavage furrow , mainly to the basal side of the furrow. In late telophase , concentrated to the extending protrusions formed at the opposite ends of the spreading daughter cells , in vesicles at the base of the lamellipodia formed by the separating daughter cells. Colocalizes with ITGB1BP1 and metastatic suppressor protein NME2 at the edge or peripheral ruffles and lamellipodia during the early stages of cell spreading on fibronectin or collagen. Translocates from peripheral focal adhesions sites to fibrillar adhesions in a ITGB1BP1-dependent manner. Enriched preferentially at invadopodia , cell membrane protrusions that correspond to sites of cell invasion , in a collagen-dependent manner. Localized at plasma and ruffle membranes in a collagen-independent manner. .; [Isoform 5]: Cell membrane , sarcolemma . Cell junction . In cardiac muscle , isoform 5 is found in costameres and intercalated disks. .

>>Rap1 signaling pathway ;
>>Phagosome ;
>>PI3K-Akt signaling pathway ;
>>Axon guidance ;
>>Focal adhesion ;
>>ECM-receptor interaction ;
>>Cell adhesion molecules ;
>>Tight junction ;
>>Platelet activation ;
>>Leukocyte transendothelial migration ;
>>Regulation of actin cytoskeleton ;
>>Bacterial invasion of epithelial cells ;
>>Pathogenic Escherichia coli infection ;
>>Shigellosis ;
>>Pertussis ;
>>Yersinia infection ;
>>Leishmaniasis ;
>>Toxoplasmosis ;
>>Human papillomavirus infection ;
>>Pathways in cancer ;
>>Proteoglycans in cancer ;
>>Small cell lung cancer ;
>>Hypertrophic cardiomyopathy ;
>>Arrhythmogenic right ventricular cardiomyopathy ;
>>Dilated cardiomyopathy